Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system by Demetria M. Bolden, Vanessa Richardson, Taufiq Salahuddin, Kamal Henderson, Paul L. Hess, Sridharan Raghavan, David R. Saxon, P. Michael Ho, Stephen W. Waldo, Gregory G. Schwartz

Get full text

Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES by Gregory P. Geba, Ruifeng Chen, Kasturi Talapatra, Taylor Brackin, Kusha A. Mohammadi, Robert Pordy, Garen Manvelian, David J. Maron, Gregory G. Schwartz, Michael Szarek, Ph. Gabriel Steg, Sergio Fazio

Get full text